EDGAR Filing Documents for 0001193125-18-118546

Form 8-K - Current report:

SEC Accession No. 0001193125-18-118546

Filing Date

2018-04-16

Accepted

2018-04-16 16:16:04

Documents

Period of Report

2018-04-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d578672d8k.htm	8-K	24941
2	EX-4.1	d578672dex41.htm	EX-4.1	64656
3	EX-4.2	d578672dex42.htm	EX-4.2	67598
4	EX-10.1	d578672dex101.htm	EX-10.1	128006
5	EX-10.2	d578672dex102.htm	EX-10.2	70642
6	EX-10.3	d578672dex103.htm	EX-10.3	52188
7	EX-99.1	d578672dex991.htm	EX-99.1	5828
8	GRAPHIC	g5786723.jpg	GRAPHIC	10613
9	GRAPHIC	g578672g03f76.jpg	GRAPHIC	4298
	Complete submission text file	0001193125-18-118546.txt		435817

Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080

Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000

MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)